Abstract:ObjectiveOur previous study demonstrated that medroxyprogesterone acetate (MPA) is an effective oral alternative for the prevention of premature LH surge in normalovulatory woman undergoing controlled ovarian hyperstimulation (COH), and the pregnancy outcomes from FET indicated that the embryos originating from PPOS had similar developmental potential as the short protocol(1). In this study,we investigate the expression related to gonadotropin receptors, sex hormone receptors and steroidogenesis in granulosa cells of normalovulatory women undergoing IVF/ICSI treatments with hMG and MPA protocol.DesignA translational research study.Materials and MethodsHuman granulosa cells (GCs) retrieved from the patients undergoing agonist group and hMG+MPA group were quantitatively compared with qPCR and western blot for the expression of steroidogenic enzymes (stAR, Scc, HSD3B2, aromatase), gonadotropin receptors (FSHR, LHR) and sex hormone receptors (PR, ER). Serum E2 on the trigger day was measured with chemiluminescence.ResultsThe cycle characteristics and outcomes show in table. The expression of FSHR and PR, at both the mRNA and protein levels, were significantly higher in hMG+MPA group than agonist group .While the expression of steroidogenic enzymes were similar between the two groups. The serum E2 level on the trigger day in the two groups was 3811.9 pg/ml, 3836.4 pg/ml, respectively, with no statistic significance (p>0.05).ConclusionsTabled 1Cycle characteristics and outcomes.Agonist group (N=50)HMG+MPA (N=68 )Age(y)32.3±3.731.3±3.7Body mass index(kg/m2)21.4±2.220.9±2.4Antral follicle count(n)10.0±4.511.2±3.4b FSH(IU/L)5.6±1.35.7±1.2hMG dose(IU)1489.5±45.8a1865.1±304.4bOocytes retrieved(n)11.0±6.2a13.7±6.3bMIIoocyte(n)9.3±5.8a12.1±5.6bFertilized oocytes(n)7.5±4.5a9.4±4.9bTop-quality embryos(n)3.2±3.6a4.8±3.6bCancellation rate(%)20.0(10/50)a5.8(4/68)bClinical pregnancy rate per transfer(%)0.3(4/16)0.4(21/51) Open table in a new tab References:1.Kuang YP, Chen QJ, Fu YL,et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing contolled ovatian huperstimulation for in vitro fetilization. Fertil Steril. 2015;104:62-70. ObjectiveOur previous study demonstrated that medroxyprogesterone acetate (MPA) is an effective oral alternative for the prevention of premature LH surge in normalovulatory woman undergoing controlled ovarian hyperstimulation (COH), and the pregnancy outcomes from FET indicated that the embryos originating from PPOS had similar developmental potential as the short protocol(1). In this study,we investigate the expression related to gonadotropin receptors, sex hormone receptors and steroidogenesis in granulosa cells of normalovulatory women undergoing IVF/ICSI treatments with hMG and MPA protocol. Our previous study demonstrated that medroxyprogesterone acetate (MPA) is an effective oral alternative for the prevention of premature LH surge in normalovulatory woman undergoing controlled ovarian hyperstimulation (COH), and the pregnancy outcomes from FET indicated that the embryos originating from PPOS had similar developmental potential as the short protocol(1). In this study,we investigate the expression related to gonadotropin receptors, sex hormone receptors and steroidogenesis in granulosa cells of normalovulatory women undergoing IVF/ICSI treatments with hMG and MPA protocol. DesignA translational research study. A translational research study. Materials and MethodsHuman granulosa cells (GCs) retrieved from the patients undergoing agonist group and hMG+MPA group were quantitatively compared with qPCR and western blot for the expression of steroidogenic enzymes (stAR, Scc, HSD3B2, aromatase), gonadotropin receptors (FSHR, LHR) and sex hormone receptors (PR, ER). Serum E2 on the trigger day was measured with chemiluminescence. Human granulosa cells (GCs) retrieved from the patients undergoing agonist group and hMG+MPA group were quantitatively compared with qPCR and western blot for the expression of steroidogenic enzymes (stAR, Scc, HSD3B2, aromatase), gonadotropin receptors (FSHR, LHR) and sex hormone receptors (PR, ER). Serum E2 on the trigger day was measured with chemiluminescence. ResultsThe cycle characteristics and outcomes show in table. The expression of FSHR and PR, at both the mRNA and protein levels, were significantly higher in hMG+MPA group than agonist group .While the expression of steroidogenic enzymes were similar between the two groups. The serum E2 level on the trigger day in the two groups was 3811.9 pg/ml, 3836.4 pg/ml, respectively, with no statistic significance (p>0.05). The cycle characteristics and outcomes show in table. The expression of FSHR and PR, at both the mRNA and protein levels, were significantly higher in hMG+MPA group than agonist group .While the expression of steroidogenic enzymes were similar between the two groups. The serum E2 level on the trigger day in the two groups was 3811.9 pg/ml, 3836.4 pg/ml, respectively, with no statistic significance (p>0.05). ConclusionsTabled 1Cycle characteristics and outcomes.Agonist group (N=50)HMG+MPA (N=68 )Age(y)32.3±3.731.3±3.7Body mass index(kg/m2)21.4±2.220.9±2.4Antral follicle count(n)10.0±4.511.2±3.4b FSH(IU/L)5.6±1.35.7±1.2hMG dose(IU)1489.5±45.8a1865.1±304.4bOocytes retrieved(n)11.0±6.2a13.7±6.3bMIIoocyte(n)9.3±5.8a12.1±5.6bFertilized oocytes(n)7.5±4.5a9.4±4.9bTop-quality embryos(n)3.2±3.6a4.8±3.6bCancellation rate(%)20.0(10/50)a5.8(4/68)bClinical pregnancy rate per transfer(%)0.3(4/16)0.4(21/51) Open table in a new tab References:1.Kuang YP, Chen QJ, Fu YL,et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing contolled ovatian huperstimulation for in vitro fetilization. Fertil Steril. 2015;104:62-70. References:1.Kuang YP, Chen QJ, Fu YL,et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing contolled ovatian huperstimulation for in vitro fetilization. Fertil Steril. 2015;104:62-70.

Impact of Progesterone on Inhibins During Controlled Ovarian Stimulation

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

Impact of Progesterone Level of Late Follicular Phase on Outcome of in Vitro Fertilization

The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation.

Impact of progesterone level after HCG administration on the outcome of IVF in long GnRH-agonist pituitary suppression protocol

Elevated progesterone on the trigger day does not impair the outcome of Human Menotrophins Gonadotrophin and Medroxyprogesterone acetate treatment cycles

Progesterone Affects Clinic Oocyte Yields by Coordinating with FSH Via the PI3K/AKT and MAPK Pathways

Effects of high progesterone on outcomes of in vitro fertilization-embryo transfer in patients with different ovarian responses.

Impact of Non-GnRH-a Down-regulated Hormone Replacement Therapy and hMG Stimulation as Endometrial Preparation Protocols on Frozen-thawed Embryo Transfer

Progestin-primed Ovarian Stimulation with or Without Clomiphene Citrate Supplementation in Normal Ovulatory Women Undergoing in Vitro Fertilization/intracytoplasmic Sperm Injection: A Prospective Randomized Controlled Trial.

Progesterone Affects Clinic Oocyte Yields by Coordinating with Follicle Stimulating Hormone Via PI3K/AKT and MAPK Pathways.

Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: an analysis of 1188 cycles

Clinical Outcomes of Using Three Gonadatropins and Medroxyprogestrone Acetate (MPA) During Ovarian Stimulation in Normal Ovulatory Women Undergoing IVF/ICSI Treatments

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

Negative Effect of Elevated Progesterone before hCG Administration on Outcome of in vitro Fertilization

Association between duration of progesterone supplementation and clinical outcomes in artificial frozen-thawed embryo transfer cycles

Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.

Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles

The Competent Function of Granulosa Cells During Ppos in Normalovulatory Women Undergoing Ivf/Icsi Treatments.

Impact of progesterone concentration on human chorionic gonadotropin trigger day on clinical outcomes with one top-quality cleavage-stage embryo or blastocyst transfer in fresh in vitro fertilization cycles